Physical Activity in Men Newly Diagnosed With Prostate Cancer: A Feasibility Study
NCT ID: NCT03331458
Last Updated: 2019-08-26
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
13 participants
INTERVENTIONAL
2018-04-17
2019-03-21
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
The purpose of this study is to
1. Measure physical activity levels and functional capacity in men newly diagnosed with prostate cancer prior to treatment and
2. Explore whether a 2-week physical activity intervention is feasible during the pre-treatment timeframe:
1. Examine intervention safety and tolerance by self-report
2. Examine changes in functional capacity by 6-minute walk test
3. Examine changes in symptom experience by self-report
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Effects of 6 Week Reduced Exertion High Intensity Interval Training Protocol in Patients With Prostate Cancer
NCT03308734
Remotely Monitored Exercise Interventions in Patients with MCSPC Undergoing ADT (Prostate 006)
NCT06429813
Impact of Exercise on Prognostic Biomarkers Related to Prostate Cancer
NCT03397030
Exercise for Prostate Cancer Patients
NCT00815672
The Effect of Exercise on Tumor Hypoxia in Men With Localized Prostate Cancer Undergoing Radical Prostatectomy.
NCT03675529
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
SUPPORTIVE_CARE
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
subjects with prostate cancer
exrecise intervention
Subjects will undergo pre-intervention measures, complete a daily physical activity diary, and post-intervention measures
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
exrecise intervention
Subjects will undergo pre-intervention measures, complete a daily physical activity diary, and post-intervention measures
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* will not start treatment for at least 2 weeks
* able to read and understand English
* capable of giving informed consent
* at least 18 years old
Exclusion Criteria
* unable to provide informed consent as assessed by the interviewer
* too sick to participate, as judged by a member of the research team or the exercise physiologist
* have been treated for another cancer
18 Years
MALE
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Duke University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Deborah Allen
Role: PRINCIPAL_INVESTIGATOR
Duke University
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Duke Raleigh Cancer Center
Raleigh, North Carolina, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
Pro00083320
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.